Evidence map›Paper›PMID 37373397›Full record

ArticleInternational journal of molecular sciences2023

A Protocol for Low-Input RNA-Sequencing of Patients with Febrile Neutropenia Captures Relevant Immunological Information.

Victoria Probst, Lotte Møller Smedegaard, Arman Simonyan, Yuliu Guo, Olga Østrup, Kia Hee Schultz Dungu, Nadja Hawwa Vissing, Ulrikka Nygaard, Frederik Otzen Bagger

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Victoria ProbstDepartment of Genomic Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Lotte Møller SmedegaardDepartment of Paediatrics and Adolescent Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Arman SimonyanDepartment of Genomic Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Yuliu GuoDepartment of Genomic Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Olga ØstrupDepartment of Genomic Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Kia Hee Schultz DunguDepartment of Paediatrics and Adolescent Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Nadja Hawwa VissingDepartment of Paediatrics and Adolescent Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Ulrikka NygaardDepartment of Paediatrics and Adolescent Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Frederik Otzen BaggerDepartment of Genomic Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.ORCID 0000-0003-0636-8845
Rigshospitalet · DKUniversity of Copenhagen · DK

Funding

Børnecancerfonden 2017-2076Danish Cancer Society R167-A11072-17-S2Danish Ministry of Higher Education and Science 0237-00004BInnovation Fund Denmark 0176-00020BLundbeck Foundation R-249-2017-1300
6 · The paper itself

Abstract

Improved methods are needed for diagnosing infectious diseases in children with cancer. Most children have fever for other reasons than bacterial infection and are exposed to unnecessary antibiotics and hospital admission. Recent research has shown that host whole blood RNA transcriptomic signatures can distinguish bacterial infection from other causes of fever. Implementation of this method in clinics could change the diagnostic approach for children with cancer and suspected infection. However, extracting sufficient mRNA to perform transcriptome profiling by standard methods is challenging due to the patient's low white blood cell (WBC) counts. In this prospective cohort study, we succeeded in sequencing 95% of samples from children with leukaemia and suspected infection by using a low-input protocol. This could be a solution to the issue of obtaining sufficient RNA for sequencing from patients with low white blood cell counts. Further studies are required to determine whether the captured immune gene signatures are clinically valid and thus useful to clinicians as a diagnostic tool for patients with cancer and suspected infection.

Indexed as

Bacterial InfectionsFebrile NeutropeniaLeukopeniaNeoplasmsAnti-Bacterial AgentsChildFeverHumansProspective StudiesRNAAnti-Bacterial AgentsRNAfebrile neutropenialow-input RNA-sequencingneutropeniapaediatricstranscriptomicswhite blood cells

Identifiers

PMID37373397
PMCPMC10299151
OpenAlexW4381166537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.